Healthcare-focused private equity firms DW Healthcare Partners (DWHP) and Linden Capital Partners are to acquire Edge Systems.
Headquartered in Signal Hill, California, Edge is a manufacturer and marketer of non-invasive equipment and consumables used in aesthetic skin health treatments.
Edge's leading product is the HydraFacial line of facial skin rejuvenation devices, which provide a non-invasive, multistep treatment in one sitting that delivers results without downtime or irritation. Edge has a current installed base of over 7,000 systems placed with dermatologists, plastic surgeons, and medical spas across 75 countries.
As part of an aesthetics sector effort, Linden and DWHP teamed up with Clint Carnell and Steve Fanning, who will be named CEO and chairman of Edge, respectively.
Carnell is a 25-year medical device and aesthetics veteran who previously held leadership positions at Solta Medical, Covidien and Bausch & Lomb.
Fanning has an extensive background in healthcare, aesthetics, and consumer pharmaceuticals. Currently CEO of Z-Medica, Fanning has also served as CEO of Solta Medical, CEO of Ocular Sciences, and held various senior leadership positions at Johnson & Johnson.
"Edge is recognised as a pioneer in non-invasive aesthetic treatments, and we are excited by the continued growth potential of this business," says Fanning. "With a unique technology and strong track record of customer and end-user satisfaction, Edge is well-positioned to address the growing demand for non-invasive facial rejuvenation treatments."
Other key advisers joining the Edge Systems board of directors include Howard Kelly, former CEO of Alma Lasers, and Glenn Novotny, the previous chairman of Edge Systems who oversaw its growth to date.
Edge will also receive the continued support of Bill Cohen and Roger Ignon, who co-founded Edge.
